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Abstract
Background—Brain atrophy in subjects with mild cognitive impairment (MCI) introduces 
partial volume effects, limiting the sensitivity of diffusion tensor imaging to white matter 
microstructural degeneration. Appropriate correction isolates microstructural effects in MCI that 
might be precursors of Alzheimer’s disease (AD).
Methods—Forty-eight participants (18 MCI, 15 AD and 15 healthy controls) had MRI scans and 
clinical evaluations at baseline and follow-up after 36 month. 10 MCI subjects were diagnosed 
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with AD at follow-up and 8 remained MCI. Free-water corrected measures on the white matter 
skeleton were compared between groups.
Results—Free-water-corrected radial diffusivity, but not un-corrected radial diffusivity, was 
increased across the brain of the converted group compared to the non-converted group (P<0.05). 
The extent of increases was similar to that found comparing AD with controls.
Conclusion—Partial volume elimination reveals microstructural alterations preceding dementia. 
These alterations may prove to be an effective and feasible early biomarker of AD.
Keywords
Alzheimer’s Disease; Mild Cognitive Impairment; Diffusion Tensor Imaging; Partial Volume 
Elimination; Free-water Imaging
1. Background
Magnetic resonance imaging (MRI) can identify pathological brain alterations associated 
with Alzheimer’s disease (AD) (1). These include macrostructural effects such as gray 
matter (GM) and white matter (WM) atrophy, as well as microstructural WM alterations, 
such as Wallerian degeneration and compromised myelin integrity. GM atrophy can be 
identified using volumetric measures based on anatomical MRI, whereas microstructural 
alterations can be identified using diffusion MRI (dMRI), a method that is sensitive to 
micron scale tissue architecture (2).
Mild cognitive impairment (MCI) is often a pre-stage of Alzheimer’s disease (AD) with a 
tenfold higher risk of developing dementia compared with healthy subjects (3). Therefore, 
the detection of imaging abnormalities in MCI may increase our understanding of the 
pathogenesis of AD, as it may lead to improved early detection of patients at risk, and may 
thus provide an objective means for the assessment of medication(s) in early stage clinical 
trials. MRI studies have not yet been able to provide a robust diagnostic measure for the 
early stages of the disease (4). Specifically, dMRI studies report inconsistent findings when 
comparing patients with MCI and controls, even when using similar analysis methods (e.g. 
see tract based spatial statistics (TBSS) studies in Table S1).
The inconsistent findings in MCI might stem from the fact that the cognitive deficits of 
some patients may stabilize, improve, or progress to other dementias (5). Patients with MCI 
are also likely to have different underlying pathology, as for example some subjects have 
AD pathology in the form of neurofibrillary tangles of hyperphosphorylated tau (p-tau) and 
beta amyloid (Aβ) neuritic plaques (6), which may be responsible for the MCI, while others 
may not have AD pathology, and their MCI is due to other pathologies (5). Therefore, 
patients with MCI do not comprise one clinical entity, which limits the predictive validity of 
MCI imaging abnormalities as a pre-dementia syndrome and/or as biomarkers of AD 
pathology (7–10).
Another limiting factor in the study of patients with MCI and AD is the influence of brain 
atrophy on the sensitivity of dMRI to microstructural changes. Part of the atrophy is likely 
age associated, since atrophy also appears in normal aging (11). Moreover, many structural 
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MRI studies have demonstrated increased GM atrophy (e.g., hippocampi, entorhinal cortex, 
amygdala) and WM atrophy (e.g., Corpus callosum) in patients with AD or MCI in 
comparison with age-matched controls (12, 13). Atrophy in subjects with MCI might be an 
early manifestation of AD pathology (14). Nevertheless, atrophy has limited specificity as a 
pre-curser of AD, as it may appear both in subjects with MCI who will develop AD and also 
appear in those who will not, as well as in patients with other brain disorders. Atrophy 
introduces macroscopic morphological changes in WM, such as loss of volume, reduced 
cellular density and increased extracellular space (15), which due to the limited resolution of 
dMRI, increases the influence of partial volume between different tissues (16). Unless these 
macroscopic morphological changes are accounted for, they decrease dMRI specificity and 
lead to difficulties in the interpretation of derived measurements. Thus, the partial volume 
effects associated with variable amounts of atrophy may have affected the interpretation of 
previous data (16). This, in conjunction with the group heterogeneity, might explain the 
diversity of previous findings regarding dMRI alterations in MCI.
Our aim is to decouple macroscopic and microscopic effects and obtain dMRI derived 
microstructural precursors of dementia by studying a sample of subjects diagnosed with 
MCI who were followed for 3 years after an initial MRI scan. Within this period, some 
subjects developed dementia and were diagnosed with AD, while others did not. By 
comparing these two subsets of MCI subjects, we were able to identify abnormalities that 
may constitute an early precursor of AD. These abnormalities were revealed only when 
controlling for partial-volume effects by applying the free-water imaging method (17), 
which corrects each image voxel for contamination from freely diffusing extracellular water 
molecules. The method separately models the contribution of such molecules from water 
molecules that are in the vicinity of cellular membranes such as axonal membrane and 
myelin sheath (18). By eliminating the extracellular contribution, the method accounts for 
partial-volume that could be introduced by atrophy, and makes it possible to identify 
whether or not microstructural changes, such as WM degeneration occur (16).
2. Methods
2.1 Study populations
This study comprised 48 subjects including 18 patients diagnosed with MCI, 15 patients 
diagnosed with AD, and 15 age-matched healthy control subjects (HC). A demographic and 
clinical characterization of the groups can be found in Table 1. Group effects were evaluated 
using analysis of deviance for the generalized linear model implemented in MathWorks 
Matlab (R2012a, 7.14.0.739). Global cognitive deficits were assessed using the mini-mental 
state examination (MMSE). Cognitive performance was investigated with a standardized 
extensive neuropsychological test battery (CERAD). Subjects were classified as healthy if 
they scored within the age- and education-adjusted norm with respect to each of the CERAD 
subtests. The MCI diagnosis was defined by Levy’s criteria of aging-associated cognitive 
decline (19) (see supplement S1). Mild to moderate AD was defined by the NINCDS-
ADRDA-criteria. The clinical evaluation of all subjects included ascertainment of personal 
and family history, as well as physical, neurological, and neuropsychological examinations. 
Those with a history of ischemic heart disease, cancer, extensive macro- and 
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microangiopathic changes on MRI, and severe cerebrovascular risk factors (e.g. instable 
hypertension or poorly controlled diabetes) were excluded. An MRI scan and a clinical 
evaluation took place at the time of recruitment. Clinical re-evaluation of the patients with 
MCI was performed three years after inclusion in the study (range 35–37 months). MRI was 
not acquired during re-evaluation. During these 3 years, 10 patients with MCI diagnostically 
converted to AD (MCI-c), while the remaining 8 patients with MCI maintained stable (MCI-
nc). The local institutional review board approved all study protocols, written informed 
consent was obtained from all patients or their legal guardians.
2.2 Image acquisition and preprocessing
Imaging (MPRAGE and dMRI) was performed on a 1.5T clinical scanner. The acquisition 
and preprocessing protocol is described in the supplements (S2).
2.3 Diffusion MRI processing
The diffusion tensor imaging (DTI) model was fitted using the tensor toolkit (https://
gforge.inria.fr/projects/ttk) and used to quantify fractional anisotropy (FA), radial diffusivity 
(RD), and axial diffusivity (AXD). The AXD and RD measures, in particular, have been 
shown to be associated with microstructural changes that are related to WM degeneration 
(20).
In addition to the DTI model, we analyzed the data using the free-water imaging model (17), 
which assumes a separate free-water compartment with a fixed diffusivity of 3×10−5 
mm2/sec (the diffusion coefficient of free-water at body temperature). Mapping the 
fractional volume of the free-water compartments provides a free-water map (FW). A 
second compartment (the tissue compartment) fits the remaining signal, which originates 
from intra- and extracellular water molecules in the proximity of cellular membranes, i.e., 
from brain tissue (18). The tissue compartment is modeled by a diffusion tensor, and 
therefore yields the same type of maps as the DTI method, only now these maps are 
corrected for contamination by a freely diffusing extracellular compartment (FA-cor, RD-
cor, and AXD-cor), and are thus expected to be more specific to WM degeneration than the 
measures derived from DTI alone (16, 18). The free-water model was implemented in mitk 
(http://www.mitk.org). Recently, free-water corrected maps have shown increased 
specificity to microstructural changes with increased sensitivity to changes that occur in 
MCI (21, 22) and normal aging, compared with non-corrected measures.
In order to detect global patterns of WM degeneration, we aligned all subjects to a common 
space using a two-step registration approach directly on the tensor images using DTITK 
(http://www.nitrc.org/projects/dtitk). First, a template was bootstrapped (23), using the IXI 
aging template (24). Then, a population-specific template space was created by means of 
affine and diffeomorphic registration (23). We used TBSS (25) to build a common WM 
skeleton from FA images derived from the coregistered tensor images. We then mapped all 
dMRI measures (both with and without free-water elimination) onto the skeleton.
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2.4 Volumetric measures
Cortical reconstruction and volumetric segmentation was performed using Freesurfer (26). 
The total GM (both cortical and sub-cortical) and WM volumes, normalized by the 
intracranial volume, were computed and the quality of the segmentation was visually 
evaluated for gross registration mistakes, resulting with the exclusion of one AD subject 
from the volumetric analysis.
2.5 Statistical analysis
Clinical scores were analyzed by means of t-tests and analysis of variance (ANOVA) using 
Stata 9 (StataCorp LP).
TBSS group comparisons between the AD and HC groups and the MCI-c and MCI-nc 
groups, with age as a covariate, were performed using threshold-free cluster enhancement 
(27) via a non-parametric test with 5000 permutations (Randomize, FSL), and a significance 
threshold of p=0.05 corrected for multiple comparisons. The group comparisons were done 
separately for each diffusivity measure (either free-water corrected or not). We tested 
whether the GM or WM volume is correlated with FW using a Pearson Correlation test 
between the respective volumes and the mean FW over the entire WM skeleton of each 
subject. We tested for group effects in the GM and WM volumes using an analysis of 
deviance for the generalized linear model as implemented in MathWorks Matlab (R2012a, 
7.14.0.739), with the GM and WM volumes being modeled as dependent and the group 
labels and age as independent variables.
3. Results
3.1 Clinical scores
The MMSE scores and statistical analysis of the different groups at recruitment and follow-
up are presented in the supplements (S3). At time of recruitment, there was no significant 
mean MMSE score difference between the HC group and the MCI-c as well as the MCI-nc 
groups.
3.2 Free-water (FW) maps
Many of the WM skeleton voxels in the AD group were found to have higher values of FW 
when compared to the HC group (Fig. 1a). Significant (p<0.05) differences were identified 
in areas including the frontal, temporal, and parietal lobes, bilaterally, in an equal measure. 
Comparing the MCI-c and MCI-nc groups showed no significant differences in FW.
3.3 Association between FW values and total GM volume
Comparing the average FW estimates on the WM skeleton with the total GM and WM 
volumes tested the association between FW content in the WM and atrophic brain processes. 
While WM volume did not exhibit a significant group effect (F(41)=1.0721; p=0.38269), 
significant group effects were found for the GM volume (F(41)=6.5542; p<10−3) and FW 
(F(41)=8.628; p<10−4). Further analysis revealed that the AD group had significantly 
increased mean FW comparing with the HC group (t(26)=−3.03; p<10−2; Fig. 1b). 
Similarly, total GM volume was significantly decreased between the AD group and the HC 
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group (t(26)=3.42; p<10−2; Fig. 1c). No significant differences were identified when 
comparing the mean FW (t(14)=−0.88; p=0.393; Fig. 1b) or total GM volume (t(14)=0.74; 
p=0.471; Fig. 1c) between the MCI-c and MCI-nc groups.
Correlating the average FW estimates on the WM skeleton for all subjects (all groups 
combined n=46) with their respective total GM volumes, we found a highly significant 
negative correlation (Fig. 1d; Pearson’s R = −0.6693; p<10−6), i.e., the more GM atrophy 
present, the higher were the FW values. WM volume did not correlate significantly with FW 
(Pearson’s R = −0.2195; p=0.1428), nor did it correlate with GM volume (Pearson’s R = 
0.0516; p=0.7332).
3.4 Diffusion MRI analysis
Having established that the free-water measure in the WM of this population is associated 
with GM atrophy, we next investigate how the free-water correction affected the 
identification of significant group differences of DTI measures that are indicative of 
microstructural WM degeneration.
Radial diffusivity (RD)—Comparison of the WM skeleton between AD and HC (Fig. 2) 
demonstrated that the AD group had a widespread significant increase of RD. Controlling 
for partial-volume by using free-water elimination had little or no impact on these results, as 
the significant group differences were apparent in both the non-corrected (RD, Fig. 2a) and 
the free-water corrected (RD-cor, Fig. 2b) measures (p<0.05). This was despite the fact that 
the AD group had significantly higher FW values than the HC group (see above, and Fig. 2). 
The two corrected and non-corrected RD measures overlapped, with a small fraction of 
voxels on the WM skeleton that was identified by only one of the measures. The areas where 
RD and RD-cor overlap included the frontal, temporal, and parietal lobes, bilaterally, in an 
equal measure, similar to the extent of increased FW reported above. These areas included 
the medial temporal, retrosplenial regions, anterior commissure, corona radiata, internal 
capsule, corticopontine tracts, cerebral peduncle, striatum, and precentral gyrus. In a recent 
study microstructural differences independent of volumetric changes were found in these 
areas in AD (28). The small areas that were identified using only RD or only RD-cor were 
scattered throughout the brain without a clear pattern.
Comparison of the WM skeleton between the MCI-c and MCI-nc groups (Fig. 3) showed 
that the MCI-c group had significantly increased non-corrected RD (Fig. 3a) only within a 
small subset of voxels, all within the Corpus callosum. On the other hand, correcting for 
free-water revealed widespread significantly increased RD-cor values (p<0.05) for the MCI-
c group (Fig. 3b). In other words, controlling for atrophy using the free-water elimination 
method drastically increased the number of areas where WM degeneration in the MCI-c 
group was identified. The areas identified with the RD-cor measure included the areas that 
were identified using the non-corrected RD values. The extent of increased RDcor identified 
for the MCI-c group was similar to the extent of the increased RD-cor identified for the AD 
group (compare Fig 2b with Fig. 3b), although the extent of findings in the MCI-c group 
was slightly reduced, and in particular the frontal lobe was less affected. Specifically, the 
orbitofrontal cortex was bilaterally affected in MCI-c, with a predominance of the left 
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hemisphere. The cingulate gyrus was affected bilaterally in an equal measure. The right-
sided dorsolateral prefrontal cortex was spared in MCI-c, whereas the left side was affected. 
In AD, both sides were affected in an equal measure.
Other diffusivities—Significant differences (p<0.05) between the AD and HC groups in 
FA, FA-cor, AXD, and AXD-cor were less extensive than RD-cor (not shown). Comparing 
the MCI-c and MCI-nc groups showed significantly lower FA-cor (p<0.05) only within the 
Corpus callosum, and no significant differences in FA, AXD, or AXD-cor.
4. Discussion
Our results indicate that widespread WM microstructural abnormalities, detected after 
correction for partial volume effects, are associated with the development of dementia due to 
AD. These abnormalities are likely indicative of WM degeneration and were found in 
patients with MCI, preceding the onset of dementia, as well as in subjects who are already 
diagnosed with AD. These early signs of neurodegenerative processes were found across the 
brain.
The most important finding in our study is that there was a widespread and significant RD-
cor increase in the MCI-c group comparing with the MCI-nc group. This increase was 
similar in extent to that evinced when comparing the AD group with healthy controls, 
suggesting that neurodegenerative processes are present even before the onset of dementia in 
those subjects with MCI who will convert to AD in the future. DTI Findings in the early 
stages of AD and in MCI have been reported previously (29, 30). Of particular note are our 
findings in the frontal lobe. It is generally accepted that the destructive process during the 
clinical course of AD follows a characteristic pattern, in which the frontal lobe is involved in 
the isocortical stage, with frontal lobe-related neurocognitive deterioration appearing only in 
the late stages of AD and absent in the MCI subjects (6). Accordingly, we find reduced 
frontal lobe involvement in MCI-c comparing with AD. Nevertheless, the frontal lobe areas 
that show increased RD-cor in the MCI-c group strongly suggest that this pathology 
precedes the manifestation of frontal lobe-related symptoms (e.g. inhibition) that are absent 
in MCI. DTI Findings in the early stages of AD and in MCI have been reported previously 
(29, 30). However, studies that did not separate MCI-c from MCI-nc are limited in their 
reproducibility (see Table S1), and studies that performed this separation were either limited 
to the analysis of regions of interest (9, 31, 32) or used supervised learning for classification 
(33, 34). Thus, none of these studies has thus far been able to demonstrate the extent of 
microstructural alterations in subjects with MCI that will develop dementia. One previous 
study used TBSS for the examination of group differences between MCI-c and MCI-nc, but 
that study did not find a significant group difference and did not correct for partial volume 
(35). Here, by associating the FW measure with the GM volume we are able to demonstrate 
that atrophy related processes are likely affecting the ability to identify microstructural DTI 
differences in the WM of subjects with MCI and that following free-water elimination, such 
WM alterations are much more robustly identified. We did not find an association between 
GM and WM volumes, suggesting that at least in its early stages, atrophy mostly affects the 
extracellular volume and the density of white matter, which are not apparent in volumetric 
MRI measures of WM (15), but are apparent in the free-water measure. This is important 
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since it will potentially improve current imaging-based AD prediction methods, which 
directly benefit from imaging markers that are more sensitive and more specific to AD 
pathology.
Atrophy is known to be prominent in AD-type dementia (1), and in agreement with this 
observation, we found highly elevated GM atrophy for AD patients compared with the other 
groups. A previous study in an aging population demonstrated that dMRI quantities such as 
RD and AXD are affected by partial-volume and atrophy, with diffusivity measures 
increasing as atrophy is more severe (16). In that study, using free-water elimination to 
control for partial-volume effects eliminated group differences that were likely attributed to 
increased atrophy with aging, and did not reflect microstructural changes. In the current 
study, we similarly find that the AD subjects evince significantly increased FW comparing 
with age-matched controls, correlating with increased atrophy. However, unlike the aging 
study, in the current study there was a significant group difference even after the free-water 
correction (increased RD-cor). This suggests that in AD there are additional dMRI 
alterations that occur on a microstructural level. These additional findings are likely related 
to WM degeneration, which might appear in normal aging as well, but is known to be much 
more pronounced and wide-spread in subjects with AD (6).
In the comparison of the MCI-c and MCI-nc groups the RD-cor differences were revealed 
only following the free-water correction. This is opposite to previous free-water elimination 
studies, where the elimination of partial-volume effects served mostly to reduce group 
difference in the DTI corrected measures (16, 18). This difference can be explained by 
noting that we found a similar degree of GM atrophy between the MCI-c and MCI-nc 
groups, which means that variable amounts of partial-volume effects are expected in these 
datasets. The variable partial-volume effects dominate the signal, introducing a bias that 
prevents the identification of the much more subtle microstructural group differences. The 
free-water elimination effectively reduces this bias, making possible the identification of 
whether or not there are microstructural differences between the groups. As a result, the 
free-water eliminated DTI measures are more specific to microstructural processes that 
occur in brain tissue rather than in the extracellular space (18). In the data presented, we find 
that there are such microstructural changes between the MCI-c and MCI-nc groups (as well 
as between the AD and HC groups), whereas in previous studies on other type of 
populations, such microstructural changes were not found, or had a limited extent. Taken 
together, our results demonstrate that the free-water corrected RD (RD-cor), which 
decouples dMRI’s microstructural effects from its macrostructural effects, provides better 
separability than the total volume of GM between the MCI-c and MCI-nc groups. While it is 
likely that regional GM volumetric measures might have increased prediction power, 
previous studies have demonstrated that combining conventional DTI measures with GM 
volumetric measures increases classification accuracy of MCI from healthy controls (36). 
We therefore suggest that the free-water corrected measures could be an important addition 
to GM atrophy measures in the prediction of the development of dementia caused by AD. 
This is also supported by recent studies where free-water corrected measures in preselected 
WM connections were associated with changes in behavioral measures related to AD (21, 
22).
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We have demonstrated the importance of having a sample of subjects with dMRI 
acquisitions at baseline and a known future conversion to AD. Future longitudinal studies on 
larger numbers of patients with MCI, e.g., the diffusion MRI subset of the ADNI-2 dataset 
on which the follow-up information will eventually become available, will allow us to 
substantiate our findings. Another potential extension of our work would be the 
incorporation of the corrected diffusion measure into network analytics applied to similar 
patient groups. This could potentially be translated to the clinical domain by creating a pool 
of normative controls and detecting and comparing degeneration patterns on a single-patient 
basis (37). This information may prove useful in the individual management of patients with 
MCI, and possibly in the development of targeted drugs.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Association between free-water (FW) and atrophy in AD and MCI
(A) Widespread significantly increased FW is found between the AD group and the healthy 
control (HC) group (p<0.05 in blue, on top of the white matter skeleton in green). There 
were no significant differences between the MCI-nc and MCI-c groups (not shown). A 
gradual increase along the progression of AD in the mean FW over the entire skeleton was 
observed comparing the 4 groups (B). At the same time a gradual decrease in the GM 
volume was observed (C). (D) The FW values were highly negatively correlated with the 
GM volume (Pearson’s R = −0.6693; p<10−6), suggesting a widespread pattern of atrophy-
related changes.
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Figure 2. White matter degeneration in Alzheimer’s disease
Comparing patients diagnosed with AD and healthy controls reveals widespread 
significantly increased radial diffusivity (RD). Controlling for atrophy by using free-water 
elimination had little impact on the results as both conventional RD maps (A) and free-water 
corrected maps (RD-cor; B) identified overlapping brain areas, indicating extensive WM 
degeneration in the AD group. Significant results (p<0.05) are colored red, on top of the 
white matter skeleton in green, with (C) and (D) showing enlarged versions of the sagittal 
slice marked by the white box.
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Figure 3. White matter degeneration in subjects with MCI that were later diagnosed with AD
In a Comparison of subjects with MCI who were later diagnosed with AD (MCI-c) and 
subjects with MCI that did not develop dementia within a 3 year follow up (MCI-nc), the 
non-corrected RD measure (A) demonstrates significant increases only in a small subset of 
voxels in the Corpus callosum. Controlling for atrophy with the free-water corrected 
measure, RD-cor (B), reveals a widespread pattern of WM degeneration between the MCI-
nc and MCI-c groups. Significant results (p<0.05) are colored red, on top of the white matter 
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skeleton in green, with (C) and (D) showing enlarged versions of the sagittal slice marked 
by the white box.
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